Literature DB >> 6319452

Serotonergic stimulation of adrenocorticotropin secretion in man.

D A Lewis, B M Sherman.   

Abstract

Controversy still exists regarding the role of serotonin in the regulation of ACTH secretion. We gave normal men three oral doses (0.5, 1.0, and 1.5 mg/kg) of fenfluramine, a serotonin-releasing agent and uptake inhibitor, and a corresponding placebo. There was a significant dose-dependent stimulatory effect of fenfluramine on both ACTH and cortisol levels. After the highest dose of fenfluramine, mean ACTH and cortisol levels increased from 20.8 pg/ml and 7.3 micrograms/dl to 35.5 pg/ml and 15.1 micrograms/dl, respectively. In a separate study, normal men were pretreated with cyproheptadine, a serotonin antagonist, before the administration of fenfluramine. Cyproheptadine did not significantly alter basal ACTH or cortisol levels, but it did blunt the responses of both hormones to fenfluramine. Cyproheptadine pretreatment did not alter plasma levels of fenfluramine. These findings support a stimulatory role for serotonin in the regulation of ACTH secretion in man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319452     DOI: 10.1210/jcem-58-3-458

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.

Authors:  M L Drent; H J Adèr; E A van der Veen
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

2.  Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome.

Authors:  R W Prescott; W A Ratcliffe; P K Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

3.  The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.

Authors:  A Weizman; I Gil-Ad; D Grupper; S Tyano; Z Laron
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Antiserotonergic inhibition of calcitonin-induced increase of beta-endorphin, ACTH, and cortisol secretion.

Authors:  L Laurian; Z Oberman; E Hoerer; E Graf
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

5.  Central serotonergic stimulation of aldosterone secretion.

Authors:  Y Shenker; M D Gross; R J Grekin
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.

Authors:  D Tepavcević; Z Giljević; M Korsić; S Halimi; E Suchanek; T Jelić; I Aganović; B Kozić; V Plavsić
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.